253 related articles for article (PubMed ID: 16406714)
1. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.
Suh CH; Chun HY; Ye YM; Park HS
Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714
[TBL] [Abstract][Full Text] [Related]
2. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
[TBL] [Abstract][Full Text] [Related]
3. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
6. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
Asanuma Y; Chung CP; Oeser A; Shintani A; Stanley E; Raggi P; Stein CM
J Rheumatol; 2006 Mar; 33(3):539-45. PubMed ID: 16463434
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
Chung CP; Oeser A; Solus J; Avalos I; Gebretsadik T; Shintani A; Linton MF; Fazio S; Stein CM
J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
[TBL] [Abstract][Full Text] [Related]
8. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
Chen JL; Huang XM; Zeng XJ; Wang Y; Zhou MX; Ma YH; Li RS; Shen T
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1330-3. PubMed ID: 17727778
[TBL] [Abstract][Full Text] [Related]
9. Studies of serum C-reactive protein in systemic lupus erythematosus.
Williams RC; Harmon ME; Burlingame R; Du Clos TW
J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.
Firooz N; Albert DA; Wallace DJ; Ishimori M; Berel D; Weisman MH
Lupus; 2011 May; 20(6):588-97. PubMed ID: 21436216
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.
ter Borg EJ; Horst G; Limburg PC; van Rijswijk MH; Kallenberg CG
J Rheumatol; 1990 Dec; 17(12):1642-8. PubMed ID: 2084238
[TBL] [Abstract][Full Text] [Related]
12. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein in sera from patients with systemic lupus erythematosus.
Morrow WJ; Isenberg DA; Parry HF; Snaith ML
J Rheumatol; 1981; 8(4):599-604. PubMed ID: 7299761
[TBL] [Abstract][Full Text] [Related]
14. Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies.
Amezcua-Guerra LM; Márquez-Velasco R; Bojalil R
Inflamm Res; 2008 Dec; 57(12):555-7. PubMed ID: 19109734
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?
Enocsson H; Sjöwall C; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
Arthritis Rheum; 2009 Dec; 60(12):3755-60. PubMed ID: 19950271
[TBL] [Abstract][Full Text] [Related]
18. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
Vogt B; Führnrohr B; Müller R; Sheriff A
Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH
Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
